Ryan J. Watts, President and CEO at Denali Therapeutics Inc. (DNLI), sold 35,198 shares at $16.50 ($581K) on 2026-01-06, disclosed to the SEC on 2026-01-08.
Seasonal sale ($581k) by President and CEO — this insider has traded DNLI in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| DNLI | SELL | 2024-10-22 | $1.1M | — | Filing → |
| DNLI | SELL | 2024-08-22 | $108K | — | Filing → |
| DNLI | SELL | 2024-02-15 | $332K | — | Filing → |